VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, has announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings over three decades of international financial leadership experience, spanning global capital markets, investment banking, corporate finance, asset management, and strategic leadership. He will report to CEO and Co-Founder Christoph Antz, Ph.D., and is expected to support the company’s capital strategy, strategic opportunities, and continued development of its proprietary BiTAC(R) technology platform and oncology pipeline.
Prior to joining VERAXA, Willener served as director of corporate development at Exentis Group AG before being appointed CFO in 2025, where he led M&A initiatives, financial strategy, and key corporate functions. Earlier in his career, he held senior executive and investment positions overseeing areas including corporate finance, capital markets, investor relations, and investment portfolios exceeding CHF 30 billion in assets under management.
This appointment comes at a critical time for VERAXA as it advances its pipeline of bispecific T cell engagers, bispecific ADCs, and other innovative formats. The company’s focus on next-generation antibody-based therapeutics is underpinned by transformative technologies and rigorous quality-by-design principles, with its pipeline rapidly moving toward clinical development. The addition of a seasoned CFO like Willener is likely to enhance investor confidence and provide the financial acumen needed to navigate the complexities of the biotech sector.
Willener’s extensive background in capital markets and corporate finance will be instrumental as VERAXA seeks to fund its research and development efforts. His experience in managing large investment portfolios and leading M&A initiatives will support the company’s strategic opportunities, including potential partnerships and collaborations. The move underscores VERAXA’s commitment to strengthening its leadership team to drive growth and deliver on its mission.
For more details on the announcement, visit the full press release at https://nnw.fm/jcHOU. The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA.
